Novel combinations of neramexane for the treatment of neurodegenerative disorders

Details for Australian Patent Application No. 2008281016 (hide)

Owner Merz Pharma GmbH & Co. KGaA

Inventors Parsons, Christopher Graham Raphael; Hanschmann, Angelika; Althaus, Michael; Gebauer, Alexander; Danysz, Wojciech

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008281016

PCT Pub. Number WO2009/015844

Priority 07252976.1 27.07.07 EP; 60/962,259 27.07.07 US

Filing date 25 July 2008

Wipo publication date 5 February 2009

Acceptance publication date 25 August 2011

International Classifications

A61K 31/015 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2009/015844 Priority application(s): WO2009/015844

25 August 2011 Application Accepted

  Published as AU-B-2008281016

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008281018-Upregulation of RACK-1 in melanoma and its use as a marker

2008281015-Novel immunotherapy against neuronal and brain tumors